Ortho Clinical Diagnostics

Ortho Clinical Diagnostics is a global leader in in vitro diagnostics (IVD), with a history that began in 1939. Headquartered in Raritan, New Jersey, the company is known for its innovative diagnostic testing technologies that enhance patient care. It has made significant contributions to the field, including the development of the first blood bank product for determining Rh blood type and patented dry-slide technology, impacting over 800,000 patients daily worldwide. The company operates in more than 130 countries, with key facilities in Rochester, New York, including a Global Center of Excellence for Research & Development. Ortho's product portfolio includes automated systems and reagents for clinical chemistry, immunoassay tests for infectious diseases, immunohematology products for blood typing, and donor screening tests, including those for COVID-19. Its customer base consists of hospitals, clinical laboratories, and blood banks, all relying on Ortho's solutions for accurate and efficient diagnostic testing.

• Employees 4800
• Annual Revenue $2042800000